Bob Burrows | Vice President, Investor Relations |
Bob Kramer | President and CEO |
Rich Lindahl | Chief Financial Officer |
Nick Lenard | JPMorgan |
Brandon Folkes | Cantor |
Boris Peaker | Cowen |
Good day and thank you for standing by. Welcome to the Emergent BioSolutions Fourth Quarter and Full Year 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]